Theravance Biopharma (TBPH) Gross Margin (2013 - 2018)
Theravance Biopharma (TBPH) reported Gross Margin of 95.98% for Q4 2018, up 46.93 percentage points from 49.06% a year earlier and up 1.48 percentage points from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Gross Margin (2013 - 2018) Analysis & Trends
For FY2018, Theravance Biopharma posted Gross Margin of 98.82%, up 38.01 percentage points from FY2017.
- Gross Margin has a five-year change of -1.18 percentage points (FY2013 to FY2018).
- By year, Gross Margin came in at 60.81% in FY2017 (-33.24 pp), 94.05% in FY2016 (+5.11 pp), 88.95% in FY2015 (+23.66 pp) and 65.28% in FY2014 (-34.72 pp).
- The Q4 2018 figure ranks as the highest quarterly Gross Margin since Q3 2016.
- Year over year, Gross Margin has now increased in each of the last four quarters, with an average year-over-year change of +1.52 percentage points over the last eight quarters.
- The high point for year-over-year Gross Margin in five years was Q4 2015 (a gain of 142.62 percentage points); the low point was Q4 2014 (a drop of 224.84 percentage points).
- Per Business Quant data, the three quarters before Q4 2018 came in at 94.51% (Q3 2018), 93.83% (Q2 2018) and 90.07% (Q1 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 95.98% |
| Sep 30, 2018 | 94.51% |
| Jun 30, 2018 | 93.83% |
| Mar 31, 2018 | 90.07% |
| Dec 31, 2017 | 49.06% |
| Sep 30, 2017 | 76.96% |
| Jun 30, 2017 | 61.13% |
| Mar 31, 2017 | 81.70% |
| Dec 31, 2016 | 79.87% |
| Sep 30, 2016 | 98.26% |
| Jun 30, 2016 | 88.34% |
| Mar 31, 2016 | 95.77% |
| Dec 31, 2015 | 17.78% |
| Sep 30, 2015 | 94.57% |
| Jun 30, 2015 | 92.92% |
| Mar 31, 2015 | 98.18% |
| Dec 31, 2014 | -124.84% |
| Sep 30, 2014 | 94.18% |
| Jun 30, 2014 | 90.62% |
| Mar 31, 2014 | 80.11% |
API Access
Theravance Biopharma Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();